Xeniopro GmbH has a total of 19 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are JOHN VARGHESE, METABIO JOULLIE SA and IKEDA MOHANDO CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | United States | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Reinmüller Viktoria | 12 |
#2 | Marty Roman | 11 |
#3 | Gualtierotti Jean-Baptiste | 11 |
#4 | Wagnières Olivier | 8 |
#5 | Küppers Verena | 8 |
#6 | Zhu Jieping | 4 |
#7 | Reinmueller Viktoria | 4 |
#8 | Kuppers Verena | 3 |
#9 | Reinmuller Viktoria | 3 |
#10 | Wagnieres Olivier | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020039088A2 | Aromatic molecules for use in the treatment of pathological conditions | |
CA3109427A1 | Phenoxy(hetero)aryl ethers of antiproliferative activity | |
CA3109421A1 | Novel aromatic molecules | |
AU2018223177A1 | Aromatic compounds which enhance notch signaling, for use in therapy | |
WO2018154118A2 | Aromatic compounds which enhance notch signaling, for use in therapy | |
EP3429576A1 | Enhancers of notch signaling and their use in the treatment of cancers and malignancies medicable by upregulation of notch |